| Literature DB >> 30621066 |
Ran Yang1, Lei Fang2,3, Jia Li4, Zhenhua Zhao5, Hua Zhang6, Yongqing Zhang7.
Abstract
A high-speed counter-current chromatography (HSCCC) method, using a two-phase solvent system composed of ethyl acetate/n-butanol/methanol/water (5:1:1:5, v/v/v/v), was successfully established to separate the five iridoid glucosides 7-O-ethyl sweroside (1), secologanin dimethylacetal (2), adinoside F (3), (7R)-secologain n-butyl methyl acetal (4) and adinoside G (5) from Lonicerae Japonicae Flos. Their purities were 96.8%, 98.5%, 93.3%, 98.0% and 99.9%, respectively. All the iridoid glucosides were identified by HR-ESI-MS, 1D and 2D NMR. Compounds 3 and 5 are new iridoid glucosides. The anti-inflammatory tests showed that compounds 1⁻5 all expressed moderate inhibitory effects on β-glucuronidase release in rat polymorphonuclear leukocytes (PMNs) induced by platelet-activating factor (PAF) with IC50 values ranging from 4.52 to 6.50 µM, while the antibacterial assays demonstrated that all the compounds displayed mild inhibitory activities against Staphylococcus aureus ATCC 25923 with MIC values ranging from 13.7 to 26.0 µg/mL.Entities:
Keywords: Lonicerae Japonicae Flos; anti-inflammatory activity; antibacterial activity; high-speed counter-current chromatography; iridoid glucosides
Mesh:
Substances:
Year: 2019 PMID: 30621066 PMCID: PMC6337566 DOI: 10.3390/molecules24010197
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of compounds 1–5.
K values of target compounds in different solvent systems.
| Solvent Systems | Ratio ( |
| ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| ethyl acetate/ | 2:1:3 | 0.092 | 0.102 | 0.210 | 0.320 | 0.535 |
| ethyl acetate/ | 4:1:5 | 0.154 | 0.161 | 0.287 | 0.351 | 0.710 |
| ethyl acetate/ | 11:1:12 | 0.122 | 0.123 | 0.225 | 0.397 | 0.641 |
| ethyl acetate/ | 11:0.5:0.5:11 | 0.111 | 0.368 | 0.491 | 0.641 | 0.697 |
| ethyl acetate/ | 11:0.5:1:11 | 0.173 | 0.419 | 0.536 | 0.875 | 1.355 |
| ethyl acetate/ | 11:3:0.5:11 | 0.677 | 0.859 | 1.085 | 1.910 | 3.352 |
| ethyl acetate/ | 5:1:1:5 | 0.510 | 0.719 | 1.090 | 1.581 | 2.210 |
Figure 2HSCCC chromatogram of the crude sample from L. Japonicae Flos. Two-phase solvent system: ethyl acetate/n-butanol/methanol/water (5:1:1:5, v/v/v/v); stationary phase: upper phase; mobile phase: lower phase; flow-rate: 2.0 mL/min; revolution speed: 850 rpm; detection wavelength: 230 nm; separation temperature: 25 °C.
Figure 3(a) HPLC analysis of the crude sample; (b–f) HPLC chromatograms and UV spectra of compounds 1–5. Column: YMC-Pack ODS-A column (5 μm, 100 × 4.6 mm); mobile phase: methanol (A)-water (B) (0–40 min, 10–80% A); flow rate: 1.0 mL/min; detection wavelength: 230 nm; column temperature: 25 °C.
1H (600 MHz) NMR data of compound 1 and compounds 2–5 (δ in ppm, J in Hz).
| No | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| 1 | 5.40 s | 5.50 d (5.4) | 5.51 d (8.2) | 5.50 d (5.2) | 5.50 d (8.2) |
| 3 | 7.63 d (1.2) | 7.42 d (1.2) | 7.57 s | 7.42 d (0.9) | 7.56 s |
| 4 | - | - | - | - | - |
| 5 | 3.30 m | 2.91 m | 3.38 m | 2.93 m | 3.37 m |
| 6 | 1.72 m, 1.82 m | 1.63 ddd (12.8, 8.0, 4.5), 2.06 m | 5.54 m | 1.63 m, 2.07 m | 5.54 m |
| 7 | 5.41 s | 4.49 dd (7.1, 4.5) | 5.55 m | 4.54 dd (6.8, 4.8) | 5.50 m |
| 8 | 5.48 ddd (17.3, 10.5, 9.9) | 5.73 ddd (17.4, 10.2, 9.0) | 5.72 ddd (17.3, 10.3, 8.5) | 5.72 ddd (17.2, 10.3, 9.0) | 5.71 ddd (17.3, 10.5, 8.6) |
| 9 | 2.63 m | 2.67 m | 2.59 m | 2.67 m | 2.58 m |
| 10 | 5.27 m, 5.29 m | 5.26 brd (10.2), 5.30 brd (17.4) | 5.19 brd (10.6), 5.22 brd (17.3) | 5.26 brd (10.2), 5.30 brd (17.2) | 5.18 brd (10.5), 5.22 brd (17.3) |
| 11 | - | - | - | - | - |
| 1′ | 4.74 d (7.9) | 4.67 d (7.9) | 4.73 d (7.8) | 4.67 d (7.9) | 4.72 d (7.7) |
| 2′ | 3.45 m | 3.19 dd (8.7, 7.9) | 3.20 dd (8.8, 7.8) | 3.18 dd (8.9, 7.9) | 3.19 dd (8.8, 7.6) |
| 3′ | 3.60 t (8.5) | 3.10–3.40 m | 3.10–3.45 m | 3.10–3.40 m | 3.10–3.45 m |
| 4′ | 3.41 t (8.5) | 3.10–3.40 m | 3.10–3.45 m | 3.10–3.40 m | 3.10–3.45 m |
| 5′ | 3.65 m | 3.10–3.40 m | 3.10–3.45 m | 3.10–3.40 m | 3.10–3.45 m |
| 6′ | 3.66 m, 3.97 m | 3.66 dd (12.0, 6.0), 3.89 dd (12.0, 2.1) | 3.67 m, 3.89 dd (11.8, 1.7) | 3.65 dd (11.9, 6.0), 3.89 dd (11.9, 2.0) | 3.66 m, 3.88 dd (11.9, 1.8) |
| 11-OMe | - | 3.69 s | 3.68 s | 3.69 s | 3.67 s |
| 1′′ | 3.92 m, 3.87 m | - | - | 3.60 m, 3.40 m | - |
| 2′′ | - | - | 3.06 m, 3.05 m | 1.54 m | 3.06 m |
| 3′′ | - | - | 4.13 m, 4.11 m | 1.41 m | 4.07 m |
| 4′′ | - | - | 1.24 t (7.4) | 0.94 t (7.4) | 1.61 m |
| 5′′ | - | - | - | - | 1.39 m |
| 6′′ | - | - | - | - | 0.95 t (7.4) |
| 7-OMea | - | 3.28 s | - | 3.29 s | - |
| 7-OMeb | - | 3.29 s | - | - | - |
NMR data were obtained in chloroform-d. Data were measured in methanol-d4.
13C (150 MHz) NMR data of compound 1 and compounds 2–5 (δ in ppm).
| No | 1 | 2 | 3 | 4 | 5 | No | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 97.1 | 97. 8 | 97. 4 | 97. 9 | 97.4 | 4′ | 70.2 | 71. 5 | 71. 5 | 71. 6 | 71.5 |
| 3 | 152.3 | 153. 2 | 154.2 | 153. 3 | 154.2 | 5′ | 76.1 | 78. 4 | 78. 5 | 78. 4 | 78.5 |
| 4 | 104.7 | 111.7 | 109.5 | 111.7 | 109.5 | 6′ | 65.3 | 62.8 | 62.8 | 62.8 | 62.8 |
| 5 | 22.0 | 29. 4 | 39.6 | 29. 3 | 39.6 | 11-OMe | - | 51.7 | 51.8 | 51.7 | 51.7 |
| 6 | 29.5 | 33. 2 | 133. 5 | 33. 1 | 133.4 | 1′′ | 62.3 | - | 173.5 | 66.3 | 173.6 |
| 7 | 100.1 | 104.4 | 126.6 | 104.0 | 126.6 | 2′′ | 15.2 | - | 38.6 | 33.7 | 38.6 |
| 8 | 131.6 | 135. 8 | 135. 8 | 135. 8 | 135.8 | 3′′ | - | - | 61.8 | 20.5 | 65.6 |
| 9 | 42.4 | 45.3 | 46.3 | 45.4 | 46.3 | 4′′ | - | - | 14.5 | 14.3 | 31.8 |
| 10 | 121.2 | 119. 8 | 118. 8 | 119. 8 | 118.8 | 5′′ | - | - | - | - | 20.2 |
| 11 | 169.1 | 169. 1 | 168. 8 | 169. 1 | 168.7 | 6′′ | - | - | - | - | 14.1 |
| 1′ | 98.8 | 100.1 | 100.2 | 100.1 | 100.2 | 7-OMea | - | 53.9 | - | 53.8 | - |
| 2′ | 73.5 | 74. 6 | 74. 7 | 74. 7 | 74.8 | 7-OMeb | - | 52.5 | - | - | - |
| 3′ | 75.8 | 78. 0 | 78. 0 | 78. 1 | 78.0 |
NMR data were obtained in chloroform-d. Data were measured in methanol-d4.
Figure 41H-1H COSY (blue bold bonds) and key HMBC correlations (red arrows) of compounds 3 and 5.
Figure 5Key NOEs (blue dashed arrows) in compound 3.
Anti-inflammatory activities of compounds 1–5.
| Compound | IC50 (µM) |
|---|---|
|
| 5.90 ± 0.71 |
|
| 6.50 ± 1.10 |
|
| 4.52 ± 0.55 |
|
| 6.11 ± 0.93 |
|
| 5.35 ± 0.51 |
| Ginkgolide B | 2.21 ± 0.40 |
Antibacterial activities of compounds 1–5 against Staphylococcus aureus ATCC 25923.
| Compound | MIC (µg/mL) |
|---|---|
|
| 17.5 ± 3.1 |
|
| 23.4 ± 4.0 |
|
| 15.4 ± 2.1 |
|
| 26.0 ± 3.7 |
|
| 13.7 ± 1.9 |
| Penicillin | 0.4 ± 0.1 |